9:45 a.m.

Roundtable Discussion: Since translational research often involves more collaborative research, how will the academic system acknowledge collaborative research in its tenure process?


Discussion leader

E. Albert Reece M.D., Ph.D., M.B.A.

11:00 a.m.


11:15 a.m.

Roundtable Discussion: How should the academic community make clinical/translational research a priority and regard it as a completion of basic science findings?


Discussion leader

E. Albert Reece M.D., Ph.D., M.B.A.

12:30 p.m.


1:15 p.m.

Roundtable Discussion: How does the academic community view the translational blocks identified by members of the Clinical Research Roundtable?


Opening presentation

Nancy S. Sung, Ph.D.

Program Officer

Burroughs Wellcome Fund

2:30 p.m.

Roundtable Discussion: How can the private sector most effectively collaborate on training issues with medical schools?


Opening presentation

Rick A. Martinez, M.D.

Director, Medical Affairs

Johnson & Johnson


John Yates, M.D.

Vice President, Medical and Scientific Affairs

Merck & Co.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement